Recon: Tidmarsh resigns as CDER chief amid inquiry, lawsuit; Kimberly-Clark to buy Tylenol maker Kenvue for $40B

Recon

ReconJason Scott

Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States